“Proteomics International Laboratories Ltd (ASX:PIQ) has been invited to feature on the American...
US PromarkerD patent expanded to all kidney disease
Proteomics International is pleased to announce that the United States patent for its PromarkerD diagnostic test has been expanded to include all kidney disease.